SCHEMBL17927565

SCHEMBL17927565

O=S(=O)(c1ccccc1)n1ccc2cc(C(O)c3cc4cc(Cl)ccc4n3S(=O)(=O)c3ccccc3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 4/20 0.48
▸ PPARA Q07869 4/20 0.48
▸ PPARD Q03181 3/20 0.48
▸ HTR6 P50406 13/20 0.48
▸ RECQL P46063 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HDAC3 O15379 2/20 0.44
▸ HDAC4 P56524 2/20 0.44
▸ HDAC1 Q13547 2/20 0.44
▸ HDAC7 Q8WUI4 2/20 0.44
▸ HDAC2 Q92769 2/20 0.44
▸ HDAC10 Q969S8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17927513 0.85 HTR6 (0.69) PPARGPPARAPPARDHTR6RECQL
SCHEMBL428128 0.82 HTR6 (0.68) PPARGPPARAPPARDHTR6POLB
SCHEMBL17927594 0.81 HTR6 (0.57) HTR6RECQLPOLBL3MBTL1MEN1
SCHEMBL17927590 0.78 MEN1 (0.64) PPARGPPARAPPARDHTR6RECQL
SCHEMBL27713311 0.77 PPARG (0.58) PPARGPPARAPPARDRECQL
SCHEMBL17927517 0.77 PPARG (0.51) PPARGPPARAPPARDHTR6POLB
SCHEMBL12450032 0.75 PPARG (0.56) PPARGPPARAPPARDRECQL
SCHEMBL12096936 0.75 ACLY (0.52) PPARGPPARAPPARD
SCHEMBL947751 0.75 HTR6 (0.63) HTR6POLBL3MBTL1MEN1ALDH1A1
SCHEMBL18922797 0.74 PPARG (0.55) PPARGPPARAPPARDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233797-B1 MAP4K4 (HGK) INHIBITORS Sri int inc (US) 2019-05-08 — — EP disclosed
US-10000451-B2 MAP4K4 (HGK) inhibitors SRI INTERNATIONAL (US) 2018-06-19 — — US disclosed
US-20170320824-A1 MAP4K4 (HGK) Inhibitors SRI INTERNATIONAL (US) 2017-11-09 — — US disclosed
EP-3233797-A1 MAP4K4 (HGK) Inhibitors SRI International Inc. (US) 2017-10-25 — — EP disclosed
WO-2016114816-A1 MAP4K4 (HGK) Inhibitors SRI INTERNATIONAL (US) 2016-07-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320824-A1 MAP4K4 (HGK) Inhibitors MAP4K4, MAP4K2, MAP4K3 PPARG 3241/4885PPARA 4197/4885PPARD 4041/4885
US-10000451-B2 MAP4K4 (HGK) inhibitors MAP4K4, MAP4K2, MAP4K3 PPARG 3241/4885PPARA 4197/4885PPARD 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback